Structured evidence table for Inositol Polycystic Ovary Syndrome Meta-Analysis, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Inositol Polycystic Ovary Syndrome Meta-Analysis | PCOS is a heterogeneous condition that is associated not only with reproductive problems such as infertility, but also with an increased risk of developing metabolic disorders, including insulin resistance, type 2 diabetes, dyslipidemia, obesity, and cardiovascular disease [,]. | 3 | Habryka Julia (2026) | Effect of Myo-Inositol Supplementation in Polycystic Ovary Syndrome—Scoping Review |
| Inositol Polycystic Ovary Syndrome Meta-Analysis | However, the strength of evidence differs between outcomes, and findings reported in the literature are not always consistent. | 3 | Habryka Julia (2026) | Effect of Myo-Inositol Supplementation in Polycystic Ovary Syndrome—Scoping Review |
| Inositol Polycystic Ovary Syndrome Meta-Analysis | As a result, the reported findings are not uniform across all outcomes, and some potential benefits appear to be better supported than others.shows the mechanism of action of MI supplementation on patients suffering from PCOS. | 3 | Habryka Julia (2026) | Effect of Myo-Inositol Supplementation in Polycystic Ovary Syndrome—Scoping Review |
| Inositol Polycystic Ovary Syndrome Meta-Analysis | 1 2 3 4 5 6 7 8 9 10 11 12 13 Figure 1 PCOS is a complex endocrine disorder affecting a woman’s reproductive age and characterized by irregular menstrual cycles, clinical or biochemical hyperandrogenism, and polycystic ovary morphology seen on ultrasound examination [,]. | 3 | Habryka Julia (2026) | Effect of Myo-Inositol Supplementation in Polycystic Ovary Syndrome—Scoping Review |
| Inositol Polycystic Ovary Syndrome Meta-Analysis | Retraction Note: Evaluation of ovarian function and metabolic factors in women affected by polycystic ovary syndrome after treatment with D-Chiro-Inositol. | 4 | Laganà AS (2026) | Retraction Note: Evaluation of ovarian function and metabolic factors in women affected by polycystic ovary syndrome after treatment with D-Chiro-Inositol. |
Source documents